PRELID2 and neoplasm: Moreover, PRELID2 was positively correlated with TNM stage (P < 0.001), tumor size (P = 0.013), tumor metastasis (P < 0.01), vascular thrombosis (P < 0.001) and recurrence (P < 0.001) (Additional file 1: Table S6).